electroCore,

electroCore, Current Liabilities

The Current Liabilities of electroCore, (ECOR) as of Oct 18, 2026 is 11.30 M USD. In the previous year, Current Liabilities was 15.56 M USD — a change of -27.38% (lower).

Current Liabilities

11.30 MUSD

YoY

-27.38%

Last updated:

Current Liabilities of electroCore, is 2025 11.30 M USD. Current Liabilities of electroCore, was 2024 15.56 M USD. It decreases by -27.38% lower compared to the previous year.

The electroCore, Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
11.44 M USD
Jan 1, 2019
13.07 M USD
Jan 1, 2020
9.47 M USD
Jan 1, 2021
8.90 M USD
Jan 1, 2022
11.39 M USD
Jan 1, 2023
13.05 M USD
Jan 1, 2024
15.56 M USD
Jan 1, 2025
11.30 M USD
The electroCore, Current Liabilities history
YEARCurrent LiabilitiesYoY
11.30 MUSD-27.38%
15.56 MUSD+19.22%
13.05 MUSD+14.57%
11.39 MUSD+27.95%
8.90 MUSD-5.97%
9.47 MUSD-27.59%
13.07 MUSD+14.26%
11.44 MUSD+24.93%
9.16 MUSD-0.67%
9.22 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

electroCore, Stock analysis

What does electroCore, do? electroCore, Inc. is a medical device company based in Basking Ridge, New Jersey, operating in the Health Care sector. The company focuses on non-invasive vagus nerve stimulation (nVNS) therapy, offering a hand-held device called gammaCore. This device provides non-drug treatment for adults experiencing episodic cluster and migraine pain. electroCore's technology targets primary headaches, including migraine and cluster headache, as well as related chronic conditions such as gastric motility disorders, psychiatric issues, sleep disorders, and pain disorders. The company went public via an IPO on June 22, 2018, and currently employs 83 full-time staff. Its headquarters are located in Basking Ridge, and it operates within the Health Care industry. electroCore's primary product, gammaCore, is designed for non-invasive cervical vagus nerve stimulation, aiming to address neurological, psychiatric, gastroenterological, and respiratory conditions. The company's website is https://www.electrocore.com/. electroCore is listed under the ticker ECOR with ISIN US28531P2020. The firm's commercial stage operations emphasize non-invasive therapeutic solutions without pharmaceutical intervention. electroCore, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about electroCore, stock

Current Liabilities of electroCore, is 11.30 M USD in 2025.

Current Liabilities of electroCore, changed from 15.56 M USD to 11.30 M USD, representing a -27.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities electroCore, since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's electroCore, historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — electroCore,

All Key Metrics — electroCore,